(Q39104808)

9 September 2017

miRNAs as biomarkers of neurodegenerative disorders (English)

1 reference

9 September 2017

0 references

1 reference

Vijitha Viswambharan

1

1 reference

9 September 2017

Ismail Thanseem

2

1 reference

9 September 2017

Mahesh M Vasu

3

1 reference

9 September 2017

Suresh A Poovathinal

4

1 reference

9 September 2017

Ayyappan Anitha

5

1 reference

9 September 2017

26 January 2017

1 reference

9 September 2017

Biomarkers in Medicine

1 reference

9 September 2017

11

1 reference

9 September 2017

2

1 reference

9 September 2017

151-167

1 reference

The functions of animal microRNAs

9 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA function in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNAs in learning, memory, and neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA expression in the adult mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

The involvement of microRNAs in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

The emerging role of microRNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A blood based 12-miRNA signature of Alzheimer disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Circulating miR-125b as a biomarker of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Circulating miRNA biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-29c regulates BACE1 protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Alternative polyadenylation and miR-34 family members regulate tau expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

microRNA Profiles in Parkinson's Disease Prefrontal Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Preferential neurotrophic activity of fibroblast growth factor‐20 for dopaminergic neurons through fibroblast growth factor receptor‐1c

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Is the ubiquitin-proteasome system impaired in Huntington's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Reciprocal actions of REST and a microRNA promote neuronal identity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Study of plasma-derived miRNAs mimic differences in Huntington's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A microRNA-based gene dysregulation pathway in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Role of brain-derived neurotrophic factor in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Brain-derived neurotrophic factor in patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Disruption of CREB function in brain leads to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miRNA malfunction causes spinal motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

The role of miRNA in motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

SMN regulates axonal local translation via miR-183/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Diagnosis and treatment of Friedreich ataxia: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Epigenetic-based therapies for Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-886-3p levels are elevated in Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Current understanding of the role of microRNAs in spinocerebellar ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA profiling in the serums of SCA3/MJD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Differential micro RNA expression in PBMC from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Circulating microRNAs involved in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Genetic association and altered gene expression of mir-155 in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Differential microRNA expression in blood in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Immune regulation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Cells release prions in association with exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

A miRNA signature of prion induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA abundance is altered in synaptoneurosomes during prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0242

21 January 2018

Identifiers

DOI

10.2217/BMM-2016-0242

1 reference

9 September 2017

1 reference